Echo Therapeutics Provides Mid-Year Update to Shareholders (via PR Newswire)
Company Streamlines Cost Structure with Focus on Achieving Critical Milestones Download image Echo Therapeutics, Inc. logo. (PRNewsFoto/Echo Therapeutics, Inc.) PHILADELPHIA, July 3, 2013 /PRNewswire/ — Echo Therapeutics, Inc. (Nasdaq: ECTE), a company…